The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. Diagnostics 2021, 11, 2171

Multicancer Early Detection (MCED) represents a new and exciting paradigm for the early detection of cancer, which is the leading cause of death worldwide. Current screening tests, recommended for only five cancer types (breast, lung, colon, cervical, and prostate), are limited by a lack of complete...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Eric A., Beer, Tomasz M., Seiden, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141107/
https://www.ncbi.nlm.nih.gov/pubmed/35626398
http://dx.doi.org/10.3390/diagnostics12051243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141107/
https://www.ncbi.nlm.nih.gov/pubmed/35626398
http://dx.doi.org/10.3390/diagnostics12051243

Ejemplares similares